Tools, techniques, and challenges in preparing cytology specimens for ancillary studies: results of the ASC Optimizing Cytology and Small Biopsy Specimen Processing for Ancillary Studies task force survey.

Q2 Medicine
Jonas J Heymann, Cristiana M Pineda, Christine N Booth, Elizabeth Jenkins, Joshua R Menke, Sara E Monaco, Ritu Nayar, Michiya Nishino, Sinchita Roy-Chowdhuri, Roberto Ruiz-Cordero, Donna K Russell, Anjali Saqi, Kaitlin E Sundling, Michael J Thrall, Vanda F Torous, Christopher J VandenBussche, Paul A VanderLaan, M Lisa Zhang, Momin T Siddiqui
{"title":"Tools, techniques, and challenges in preparing cytology specimens for ancillary studies: results of the ASC Optimizing Cytology and Small Biopsy Specimen Processing for Ancillary Studies task force survey.","authors":"Jonas J Heymann, Cristiana M Pineda, Christine N Booth, Elizabeth Jenkins, Joshua R Menke, Sara E Monaco, Ritu Nayar, Michiya Nishino, Sinchita Roy-Chowdhuri, Roberto Ruiz-Cordero, Donna K Russell, Anjali Saqi, Kaitlin E Sundling, Michael J Thrall, Vanda F Torous, Christopher J VandenBussche, Paul A VanderLaan, M Lisa Zhang, Momin T Siddiqui","doi":"10.1016/j.jasc.2024.10.001","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Ancillary testing on cytopathology and other small biopsy specimens is crucial for diagnosis and provides critical information to clinicians. Testing is dependent on preanalytic factors and would benefit from standardization of specimen collection protocols across laboratories. To assess institutional practices and areas of need for evidence-based standards, we surveyed current practices across cytopathology laboratories.</p><p><strong>Materials and methods: </strong>A twelve-question electronic survey was distributed to American Society of Cytopathology (ASC) members through email, social media, and the ASC from January 8, 2024 to March 1, 2024. Survey responses were tabulated.</p><p><strong>Results: </strong>Of 294 respondents, 257 (87%) completed at least 10/12 questions. Formalin-fixed, paraffin-embedded cell blocks (CBs) are utilized for immunohistochemistry, molecular testing, and in situ hybridization by 89%, 84%, and 71% of respondents, respectively. For fine needle aspirations, no collection medium is utilized by a majority of respondents. In contrast, 61% utilize no collection medium for fluids; 64% predominantly utilize liquid-based preservatives for other exfoliative specimens. For CB preparation, 58% of respondents use coagulating agent; 67% use no fixative before formalin. The two most significant factors limiting clinical utility of ancillary testing in cytology specimens are low cellularity and lack of validation (49% and 23% of respondents, respectively).</p><p><strong>Conclusions: </strong>There is wide variation in current practices among laboratories, reflecting lack of consensus. Although laboratories utilize different collection media for different specimen types, for CB utilization, current survey results are similar to those reported previously. ASC has convened a task force to facilitate specimen standardization and minimize variability among preanalytic factors.</p>","PeriodicalId":38262,"journal":{"name":"Journal of the American Society of Cytopathology","volume":" ","pages":"55-63"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Society of Cytopathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jasc.2024.10.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Ancillary testing on cytopathology and other small biopsy specimens is crucial for diagnosis and provides critical information to clinicians. Testing is dependent on preanalytic factors and would benefit from standardization of specimen collection protocols across laboratories. To assess institutional practices and areas of need for evidence-based standards, we surveyed current practices across cytopathology laboratories.

Materials and methods: A twelve-question electronic survey was distributed to American Society of Cytopathology (ASC) members through email, social media, and the ASC from January 8, 2024 to March 1, 2024. Survey responses were tabulated.

Results: Of 294 respondents, 257 (87%) completed at least 10/12 questions. Formalin-fixed, paraffin-embedded cell blocks (CBs) are utilized for immunohistochemistry, molecular testing, and in situ hybridization by 89%, 84%, and 71% of respondents, respectively. For fine needle aspirations, no collection medium is utilized by a majority of respondents. In contrast, 61% utilize no collection medium for fluids; 64% predominantly utilize liquid-based preservatives for other exfoliative specimens. For CB preparation, 58% of respondents use coagulating agent; 67% use no fixative before formalin. The two most significant factors limiting clinical utility of ancillary testing in cytology specimens are low cellularity and lack of validation (49% and 23% of respondents, respectively).

Conclusions: There is wide variation in current practices among laboratories, reflecting lack of consensus. Although laboratories utilize different collection media for different specimen types, for CB utilization, current survey results are similar to those reported previously. ASC has convened a task force to facilitate specimen standardization and minimize variability among preanalytic factors.

为辅助研究准备细胞学标本的工具、技术和挑战:ASC 为辅助研究优化细胞学和小型活检标本处理工作组的调查结果。
导言:细胞病理学和其他小型活检标本的辅助检测对诊断至关重要,可为临床医生提供重要信息。检测取决于分析前的各种因素,各实验室标本采集方案的标准化将使检测工作受益匪浅。为了评估各机构的做法和需要循证标准的领域,我们调查了细胞病理学实验室的现行做法:从 2024 年 1 月 8 日至 2024 年 3 月 1 日,我们通过电子邮件、社交媒体和 ASC 向美国细胞病理学学会 (ASC) 会员发放了一份包含 12 个问题的电子调查问卷。调查结果已制成表格:在 294 位回复者中,257 位(87%)至少完成了 10/12 个问题。分别有89%、84%和71%的受访者使用福尔马林固定、石蜡包埋细胞块(CB)进行免疫组化、分子检测和原位杂交。对于细针穿刺,大多数受访者不使用收集介质。相比之下,61%的受访者不使用液体收集介质;64%的受访者主要使用液体防腐剂处理其他脱落标本。在 CB 制备方面,58% 的受访者使用凝固剂;67% 的受访者在使用福尔马林前不使用固定剂。限制细胞学标本辅助检测临床实用性的两个最重要因素是低细胞度和缺乏验证(分别占受访者的49%和23%):结论:各实验室目前的做法差异很大,反映出缺乏共识。尽管实验室对不同类型的标本使用不同的采集介质,但就 CB 的使用而言,目前的调查结果与之前报告的结果相似。ASC 已召集了一个特别工作组,以促进标本标准化并尽量减少分析前因素之间的差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the American Society of Cytopathology
Journal of the American Society of Cytopathology Medicine-Pathology and Forensic Medicine
CiteScore
4.30
自引率
0.00%
发文量
226
审稿时长
40 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信